Print this page    •   Back to Web version of article

Kaletra Monotherapy Controversy: amfAR Publishes Overview

October 26, 2004

The November 2004 HIV AIDS Treatment Insider (published by the American Foundation for AIDS Research) has a short overview of the controversy around using Kaletra alone for HIV treatment for some patients -- mainly as an option for those who would otherwise have no antiretroviral treatment because they could not afford it.1 A trial in Houston, Texas with 30 patients reported 48-week data at the big AIDS conference in Bangkok, Thailand in July.

The article, a fair presentation of both sides, also mentions other research plans for testing antiretroviral regimens with fewer than three drugs.

Note: The complete HIV AIDS Treatment Insider has two additional important articles: "Drug Pipelines May Flourish, But Not for HIV," by Kristen Kresge, and "Crunching the Numbers on Pharmaceuticals," by Elizabeth Paukstis. The complete issue can be read on the Web (or downloaded in PDF) at


  1. Monotherapy: An old strategy garners new interest, by Elizabeth Paukstis. HIV AIDS Treatment Insider; November 2004, volume 5, number 7,

ISSN # 1052-4207

Copyright 2004 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.

Back to the AIDS Treatment News October 26, 2004 contents page.

This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.